v3 Template
A

ABVC BioPharma, Inc.

Biotechnology / Biopharmaceuticals ~120 employees
Founded
--
Employees (Est.)
~120
8 leaders known
Total Funding
$3.5M
Funding Rounds
2
Last Funding
2023-07-31

About ABVC BioPharma, Inc.

ABVC BioPharma, Inc. is a biopharmaceutical company focused on identifying and commercializing promising new drugs and medical devices developed at world-class research institutions. Their mission is to develop safe, all-natural, plant-based therapeutics that positively impact lives and redefine the future of medicine, targeting severe illnesses such as ophthalmology disorders, depression, ADHD, and oncology.

Products & Services

Vitargus(r) - ABV-1701:A biodegradable, next-generation vitreous replacement for eye care.
ABV-2001:Intrapocular irrigation solution for eye care.
ABV-1504:A novel treatment for Major Depressive Disorder (MDD).
ABV-1505:A plant-based drug targeting ADHD symptoms in adults.
ABV-1601:Treatment for depression in cancer patients.
ABV-1501:Therapy for Triple Negative Breast Cancer.
BioKey, Inc.:A subsidiary providing contract development and manufacturing services for nutritional and pharmaceutical products.

Specialties

Plant-based medicine Ophthalmology (Eye Care) Psychiatric Disorders (Depression, ADHD) Oncology (Cancer treatments) Botanical drug development

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Registered Direct Offering
T: -
FT: Registered Direct Offering
A: 1750000
MR: -
FA: $1.75 million
FAN: 1750000
D: 2023-07-31
FD: 2023-07-31
1 investors
2 RT: Registered Direct Offering
T: -
FT: Registered Direct Offering
A: 1750000
MR: -
FA: $1.75 million
FAN: 1750000
D: 2023-07-27
FD: 2023-07-27
1 investors
Registered Direct Offering Latest
2023-07-31
$1.8M
1 investor (Pro only)
Registered Direct Offering 2023-07-27
$1.8M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

T

T. S. Jiang

Chief Scientific Officer

U

Uttam Yashwant Patil

CHIEF EXECUTIVE OFFICER

L

Leeds Chow

Chief Financial Officer

Y

Yih-Shiou Hwang

Director at the Department of Ophthalmology / School of Medicine, Chang Gung University; Chief of Uveitis and Retina Service, Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou

M

Maurizio Fava

Psychiatrist-In-Chief, Department of Psychiatry

S

Susanna Cunningham-Rundles

Professor Emerita of Research Immunology in Pediatrics, Vice Chair of Academic Affairs and Director of the Weill Cornell Cellular Immunology Laboratory

View 5 more team members with Pro

Unlock Full Team Directory

Recent News

ABVC BioPharma, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Biopharmaceuticals
Company Size
~120 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro